Literature DB >> 17311330

Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.

Matthew B Elliott1, Robert C Welliver, Todd S Laughlin, Karin S Pryharski, Natisha A LaPierre, Tong Chen, Victor Souza, Nicole B Terio, Gerald E Hancock.   

Abstract

Respiratory syncytial (RSV) and parainfluenza (PIV) viruses are primary causes of acute bronchiolitis and wheezing illnesses in infants and young children. To further understand inflammation in the airways following infection, we tested for the presence of matrix metalloproteinases (MMP) and natural tissue inhibitors of MMP (TIMP) in primary and established human cell lines, and in the nasopharyngeal secretions (NPS) of human infants infected with RSV or PIV. Using ELISA and multiplex-based assays, MMP-9 and TIMP-1 proteins were, respectively, detected in 66/67 and 67/67 NPS. During PIV or RSV infection TIMP-1 concentrations were associated with hypoxic bronchiolitis. TIMP-1 amounts were also negatively correlated with O2 saturation, and positively correlated with IL-6, MIP-1alpha, and G-CSF amounts following RSV infection. IL-6, MIP-1alpha, and G-CSF were negatively correlated with O2 saturation during RSV infection. Acute respiratory tract disease was not associated with MMP-9 protein/protease activity. Additional studies using real-time quantitative PCR suggested that MMP-9 mRNA copy numbers were elevated in normal human bronchial epithelial (NHBE) cells infected with RSV, while TIMP-1 and TIMP-2 were not increased. However, ELISA did not reveal MMP-9 protein in the NHBE cell culture supernatants. Hence, the data implied that airway epithelial cells were not the primary source of MMP or TIMP following paramyxovirus infection. Taken together, the data suggested that paramyxovirus infection perturbs MMP-9/TIMP-1 homeostasis that in turn may contribute to the severity of respiratory tract disease. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311330     DOI: 10.1002/jmv.20830

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.

Authors:  Michele Y F Kong; John P Clancy; Ning Peng; Yao Li; Tomasz J Szul; Xin Xu; Robert Oster; Wayne Sullender; Namasivayam Ambalavanan; J Edwin Blalock; Amit Gaggar
Journal:  Eur Respir J       Date:  2013-12-05       Impact factor: 16.671

Review 2.  Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants.

Authors:  Megan Meyer; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-17       Impact factor: 5.464

3.  Cigarette smoke alters tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 levels in the basolateral secretions of human asthmatic bronchial epithelium in vitro.

Authors:  Alan M Watson; Angela S Benton; Mary C Rose; Robert J Freishtat
Journal:  J Investig Med       Date:  2010-06       Impact factor: 2.895

4.  The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations.

Authors:  Tuula K Outinen; Satu M Mäkelä; Ilpo O Ala-Houhala; Heini Sa Huhtala; Mikko Hurme; Antti S Paakkala; Ilkka H Pörsti; Jaana T Syrjänen; Jukka T Mustonen
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

5.  Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Authors:  Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

6.  Systemic cytokine response profiles associated with respiratory virus-induced acute otitis media.

Authors:  Janak A Patel; Sangeeta Nair; James Grady; Krystal Revai; Sundar Victor; Allan R Brasier; Tasnee Chonmaitree
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

7.  Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections.

Authors:  Kim H Brand; Inge M L Ahout; Ronald de Groot; Adilia Warris; Gerben Ferwerda; Peter W M Hermans
Journal:  J Med Virol       Date:  2012-09       Impact factor: 2.327

8.  Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice.

Authors:  Robert F Foronjy; Abdoulaye J Dabo; Clifford C Taggart; Sinead Weldon; Patrick Geraghty
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.